ARAY — Accuray Incorporated

Accuray (ARAY) Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Net Revenue: $94 million, down 7% year-over-year and down 9% on a constant currency basis.
• Product Revenue: $37 million, a decline of 23% year-over-year, attributed to slower performance in EIMEA and China.
• Service Revenue: $57 million, an increase of 7% year-over-year, driven by a 10% growth in contract revenue.
• Gross Margin: Overall gross margin was 28.3%, down from 33.9% in the prior year. Product gross margin was notably lower at 20.3%.
• Operating Loss: $11.3 million, compared to a loss of $2.1 million in the prior year.
• Adjusted EBITDA: Loss of $4.1 million, down from an income of $3.1 million in the prior year.
• Order Backlog: Approximately $396 million, providing over 18 months of product revenue visibility.

2. Strategic Updates and Business Highlights

• Leadership Transition: Steve LaNeve, the new CEO, emphasized a commitment to transforming Accuray's operational and financial performance.
• Transformation Plan: Aimed at enhancing competitiveness, driving margin expansion, and fostering a performance-based culture.
• Product Launch: The Stellar product was launched at the ASTRO conference, receiving positive feedback and generating strong customer interest.
• Collaboration: A memorandum of understanding with the University of Wisconsin to advance adaptive radiotherapy technologies.
• International Expansion: Successful treatment of patients in Melbourne, Australia, using the CyberKnife system.

3. Forward Guidance and Outlook

• Fiscal Year 2026 Guidance: Revenue expected in the range of $471 million to $485 million, with adjusted EBITDA projected between $31 million and $35 million.
• Second Half Expectations: Anticipation that first half revenue will account for approximately 40% of full-year guidance, with the second half expected to contribute 60%, reflecting a shift in product demand.

4. Bad News, Challenges, or Points of Concern

• Declining Product Revenue: Significant drop in product revenue, particularly in key markets like EIMEA and China, raises concerns about market dynamics.
• Margin Compression: Gross margins have declined due to unfavorable sales mix, tariffs, and inventory obsolescence charges.
• Operating Losses: Increased operating loss and negative adjusted EBITDA highlight ongoing financial pressures.
• Geopolitical and Macro Issues: Continued uncertainties in global markets could impact future orders and revenue.

5. Notable Q&A Insights

• Capital Equipment Environment: Mixed signals across regions; while the U.S. market remains stable, EIMEA and China are experiencing slowdowns.
• Order Dynamics: The difference between gross and net orders was attributed to timing issues and cancellations, particularly in China.
• Tariff Mitigation Efforts: Active initiatives to manage tariff impacts, including exploring duty drawback programs and foreign trade zones.
• Service Business Growth: Continued emphasis on service revenue growth, which is expected to remain strong despite challenges in product sales.

Overall, while Accuray faces significant challenges in product revenue and margins, the new leadership's strategic initiatives and positive service revenue trends provide a foundation for potential recovery and growth.